
Opinion|Videos|February 2, 2026
Role of APPs in Shared Decision-Making in Alzheimer Disease
Author(s)Ken Cohen, MD, FACP
Panelists discuss how APPs strengthen shared decision-making through education and compassionate communication.
Advertisement
Episodes in this series

Panelists discuss how shared decision-making is vital for empowering patients and caregivers. Advance practice providers (APPs) act as educators who translate complex medical information into understandable terms, supporting informed consent.
Panelists discuss how empathy and communication skills enable APPs to align treatment goals with patient preferences and quality-of-life priorities. Continuous dialogue fosters trust and sustained engagement.
Panelists discuss how APPs ensure ongoing support throughout the disease journey, helping patients revisit decisions as conditions evolve.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
MFN Drug Agreements Could Raise Prices Worldwide
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
5
